Gedea Biotech has received 1 MSEK for clinical study for CE mark of new product

May 24, 2018
Gedea Biotech AB

Smile Company Gedea Biotech has received 1 MSEK  in Vinnova funding in Swelife and MedTech4Health's joint announcement "Project for better health". The money will finance the first clinical trial in patients with vaginal fungal infection.

Read more here